[1]
|
Nam, S.H., Kang, S.G. and Song, S.W. (2017) The Neutrophil-Lymphocyte Ratio Is Associated with Coronary Artery Calcification in Asymptomatic Korean Males: A Cross Sectionalstudy. BioMed Research International, 2017, Article ID: 1989417. https://doi.org/10.1155/2017/1989417
|
[2]
|
Karaman, M., Balta, S., Seyit Ahmet, A.Y., Cakar, M., Naharci, I., Demirkol, S., et al. (2013) The Comparative Effects of Valsartan and Amlodipine on VWF Levels and N/L Ratio in Patients with Newly Diagnosed Hypertension. Clinical and Experimental Hypertension, 35, 516-522. https://doi.org/10.3109/10641963.2012.758734
|
[3]
|
Balta, S., Kurtoglu, E., Kucuk, U., Demirkol, S. and Öztürk, C. (2014) Neutrophil-Lymphocyte Ratio as an Important Assessment Tool. Expert Review of Cardiovascular Therapy, 12, 537-538.
https://doi.org/10.1586/14779072.2014.902309
|
[4]
|
Horne, B.D., Anderson, J.L., John, J.M., Weaver, A., Bair, T.L., Jensen, K.R., et al. (2005) Which White Blood Cell Subtypes Predict Increased Cardiovascularrisk? Journal of the American College of Cardiology, 45, 1638-1643.
https://doi.org/10.1016/j.jacc.2005.02.054
|
[5]
|
Yu, X.Y., Li, X.S., Li, Y., Liu, T., Wang, R.T. (2015) Neutrophil-Lymphocyte Ratio Is Associated with Arterial Stiffness in Postmenopausal Women with Osteoporosis. Archives of Gerontology and Geriatrics, 61, 76-80.
https://doi.org/10.1016/j.archger.2015.03.011
|
[6]
|
董荣静, 石柔, 董雪娥, 颜穗珺, 李会芳. 中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值与2型糖尿病患者颈动脉粥样硬化的相关性[J]. 中华临床医师杂志(电子版), 2017, 11(2): 179-182.
|
[7]
|
Park, B.J., Shim, J.Y., Lee, H.R., Lee, J.H., Jung, D.H., Kim, H.B., et al. (2011) Relationship of Neutrophil-Lymphocyte Ratio with Arterial Stiffness and Coronary Calcium Score. Clinica Chimica Acta, 412, 925-929.
https://doi.org/10.1016/j.cca.2011.01.021
|
[8]
|
Park, J.J., Jang, H.J., Oh, I.Y., et al. (2013) Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients Presenting With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. American Journal of Cardiology, 111, 636-642.
|
[9]
|
Kotnik, P., Fischer-Posovszky, P. and Wabitsch, M. (2011) RBP4: A Controversial Adipokine. European Journal of Endocrinology, 165, 703-711. https://doi.org/10.1530/EJE-11-0431
|
[10]
|
Yang, Q., Graham, T.E., Mody, N., Preitner, F., Peroni, O.D., Zabolotny, J.M., et al. (2005) Serum Retinol Binding Protein 4 Contributes to Insulin Resistance in Obesity and Type 2 Diabetes. Nature, 436, 356-362.
|
[11]
|
Bobbert, T., Raila, J., Schwarz, F., Mai, K., Henze, A., Pfeiffer, A.F., et al. (2010) Relation between Retinol, Retinol-Binding Protein 4, Transthyretin and Carotid Intima Media Thickness. Atherosclerosis, 213, 549-551.
https://doi.org/10.1016/j.atherosclerosis.2010.07.063
|
[12]
|
Liu, Y., Wang, D., Li, D., Sun, R. and Xia, M. (2014) Associations of Retinol-Binding Protein 4 with Oxidative Stress, Inflammatory Markers, and Metabolic Syndrome in a Middle-Aged and Elderly Chinese Population. Diabetology & Metabolic Syndrome, 6, Article No. 25. https://doi.org/10.1186/1758-5996-6-25
|
[13]
|
Majerczyk, M., Kocelak, P., Choreza, P., Arabzada, H., Owczarek, A.J., Bozentowicz Wikarek, M., et al. (2018) Components of Metabolic Syndrome in Relation to Plasma Levels of Retinol Binding Protein 4 (RBP4) in a Cohort of People Aged 65 Years and Older. Journal of Endocrinological Investigation, 41, 1211-1219.
https://doi.org/10.1007/s40618-018-0856-6
|
[14]
|
Lambadiari, V., Kadoglou, N.P., Stasinos, V., Maratou, E., Antoniadis, A., Kolokathis, F., et al. (2014) Serum Levels of Retinol-Binding Protein-4 Are Associated with the Presence and Severity of Coronary Artery Disease. Cardiovascular Diabetology, 13, Article No. 121. https://doi.org/10.1186/s12933-014-0121-z
|
[15]
|
Sun, Q., Kiernan, U.A., Shi, L., Phillips, D.A., Kahn, B.B., Hu, F.B., et al. (2013) Plasma Retinol-Binding Protein 4 (RBP4) Levels and Risk of Coronary Heart Disease: A Prospective Analysis among Women in the Nurses’ Health Study. Circulation, 127, 1938-1987. https://doi.org/10.1161/CIRCULATIONAHA.113.002073
|
[16]
|
Rodríguez-Morales, A.J., Bonilla-Aldana, D.K., Suárez, J.A., Franco-Paredes, C., Forero-Peña, D.A., Mattar, S., et al. (2021) Yellow Fever Reemergence in Venezuela Implications for International Travelers and Latin American Countries during the COVID-19 Pandemic. Travel Medicine and Infectious Disease, 44, 102192.
https://doi.org/10.1016/j.tmaid.2021.102192
|
[17]
|
Ahn, N. and Kim, K. (2016) High-Density Lipoprotein Cholesterol (HDL-C) in Cardiovascular Disease: Effect of Exercise Training. Integrative Medicine Research, 5, 212-215. https://doi.org/10.1016/j.imr.2016.07.001
|
[18]
|
Kosmas, C.E., Martinez, I., Sourlas, A., Campos, F.N., Torres, V., Montan, P.D., et al. (2018) High-Density Lipoprotein (HDL) Functionality and Its Relevance to Atherosclerotic Cardiovascular Disease. Drugs in Context, 7, Article ID: 212525. https://doi.org/10.7573/dic.212525
|
[19]
|
Decharatchakul, N., Settasatian, C., Settasatian, N., Komanasin, N., Kukongviriyapan, U., Intharaphet, P., et al. (2019) Association of Genetic Polymorphisms in SOD2, SOD3, GPX3, and GSTT1 with Hypertriglyceridemia and Low HDL-C Level in Subjects with High Risk of Coronary Artery Disease. PeerJ, 7, Article No. e7407.
https://doi.org/10.7717/peerj.7407
|
[20]
|
陈明丹. 血浆致动脉硬化指数在心血管疾病中的应用进展[J]. 中国动脉硬化杂志, 2020, 28(3): 273-276.
|
[21]
|
Staiger, H., Keuper, M., Berti, L., Hrabe, D.A.M. and Haring, H.U. (2017) Fibroblast Growth Factor 21-Metabolic Role in Mice and Men. Endocrine Reviews, 38, 468-488. https://doi.org/10.1210/er.2017-00016
|
[22]
|
Recinella, L., Leone, S., Ferrante, C., Chiavaroli, A., Di Nisio, C., Martinotti, S., et al (2017) Effects of Central Fibroblast Growth Factor 21 (FGF21) in Energy Balance. Journal of Biological Regulators and Homeostatic Agents, 31, 603-613.
|
[23]
|
Sheehan, S.M. and Allen, R.E. (1999) Skeletal Muscle Satellite Cell Proliferation in Response to Members of the Fibroblast Growth Factor Family and Hepatocyte Growth Factor. Journal of Cellular Physiology, 181, 499-506.
https://doi.org/10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1
|
[24]
|
Krejci, P., Prochazkova, J., Bryja, V., Kozubik, A. and Wilcox, W.R. (2009) Molecular Pathology of the Fibroblast Growth Factor Family. Human Mutation, 30, 1245-1255. https://doi.org/10.1002/humu.21067
|
[25]
|
Ying, L., Li, N., He, Z., Zeng, X., Nan, Y., Chen, J., et al. (2019) Fibroblast Growth Factor 21 Ameliorates Diabetes-Induced Endothelial Dysfunction in Mouse Aorta via Activation of the CaMKK2/AMPKa Signaling Pathway. Cell Death & Disease, 10, Article No. 665. https://doi.org/10.1038/s41419-019-1893-6
|
[26]
|
Wang, X.M., Song, S.S., Xiao, H., Gao, P., Li, X.J. and Si, L.Y. (2014) Fibroblast Growth Factor 21 Protects against High Glucose Induced Cellular Damage and Dysfunction of Endothelial Nitric-Oxide Synthase in Endothelial Cells. Cellular Physiology and Biochemistry, 34, 658-671. https://doi.org/10.1159/000363031
|
[27]
|
Corrado, E., Rizzo, M., Tantillo, R., Muratori, I., Bonura, F., Vitale, G., et al. (2006) Markers of Inflammation and Infection Influence the Outcome of Patients with Baseline Asymptomatic Carotid Lesions: A 5-Year Follow-Up Study. Stroke, 37, 482-486. https://doi.org/10.1161/01.STR.0000198813.56398.14
|
[28]
|
Corrado, E., Rizzo, M., Coppola, G., Muratori, I., Carella, M. and Novo, S. (2008) Endothelial Dysfunction and Carotid Lesions Are Strong Predictors of Clinical Events in Patients with Early Stages of Atherosclerosis: A 24-Month Follow-up Study. Coronary Artery Disease, 19, 139-144. https://doi.org/10.1097/MCA.0b013e3282f3fbde
|
[29]
|
Burke, G.L., Evans, G.W., Riley, W.A., Sharrett, A.R., Howard, G., Barnes, R.W., et al. (1995) Arterial Wall Thickness Is Associated with Prevalent Cardiovascular Disease in Middle-Aged Adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke, 26, 386-391. https://doi.org/10.1161/01.STR.26.3.386
|
[30]
|
Corretti, M.C., Anderson, T.J., Benjamin, E.J., Celermajer, D., Charbonneau, F., Creager, M.A., et al. (2002) Guidelines for the Ultrasound Assessment of Endothelialdependent Flow-Mediated Vasodilation of the Brachial Artery: A Report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology, 39, 257-265. https://doi.org/10.1016/S0735-1097(01)01746-6
|